Enzymotec Ltd. Reports Second Quarter 2016 Unaudited Financial Results

Go back to Enzymotec Ltd. Reports Second Quarter 2016 Unaudited Financial Results

Enzymotec (ENZY) Misses Q2 EPS by 4c; Trims FY16 Outlook

August 9, 2016 7:34 AM EDT

Enzymotec (NASDAQ: ENZY) reported Q2 EPS of $0.04, $0.04 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $15 million versus the consensus estimate of $14.9 million.

GUIDANCE:

Enzymotec sees FY2016 EPS of $0.25-$0.30, versus the consensus of $0.29. Enzymotec sees... More